Researchers urge more studies on off-label use of 14 drugs

11/24/2008 | HealthDay News

Fourteen broadly prescribed medicines, including the psychiatric drug Seroquel and the blood thinner warfarin, need to be studied further to test their safety and efficacy for unapproved applications, according to a U.S. study. The lead researcher did not recommend against off-label prescription but said authorities should step up efforts to monitor the practice.

View Full Article in:

HealthDay News

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Director, Site Quality Management
CareFusion
Minneapolis, MN
In house Compliance Officer
Confidential
Pompano Beach, FL
Clinical Project Manager
Abiomed, Inc.
Danvers, MA
Sr. Manager, Regulatory Affairs - International
Integra LifeSciences
Plainsboro, NJ
Associate - Food and Drug
Keller and Heckman LLP
Washington, DC